UBS Group’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
0
| – | -$1 | – | 9182 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 8286 |
|
|
2024
Q1 | – | Sell |
-615
| Closed | -$8.3K | – | 9011 |
|
|
2023
Q4 | $8.3K | Buy |
+615
| New | +$8.3K | ﹤0.01% | 6360 |
|
|
2023
Q3 | – | Sell |
-185
| Closed | -$7.11K | – | 9062 |
|
|
2023
Q2 | $7.11K | Buy |
+185
| New | +$7.11K | ﹤0.01% | 6243 |
|
|
2023
Q1 | – | Hold |
0
| – | -$3 | – | 10114 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 9440 |
|
|
2022
Q3 | – | Sell |
-4
| Closed | -$1K | – | 10236 |
|
|
2022
Q2 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 9103 |
|
|
2021
Q4 | – | Sell |
-62
| Closed | -$24K | – | 9736 |
|
|
2021
Q3 | $24K | Buy |
62
+35
| +130% | +$13.5K | ﹤0.01% | 5861 |
|
|
2021
Q2 | $24K | Sell |
27
-27
| -50% | -$24K | ﹤0.01% | 6081 |
|
|
2021
Q1 | $65K | Sell |
54
-9
| -14% | -$10.8K | ﹤0.01% | 5305 |
|
|
2020
Q4 | $84K | Buy |
63
+56
| +800% | +$74.7K | ﹤0.01% | 4819 |
|
|
2020
Q3 | $16K | Buy |
+7
| New | +$16K | ﹤0.01% | 5620 |
|